Pharma Industry News Weekly Recap: September 1, 2023
// Biotech and Pharma Therapeutics BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, [...]
// Biotech and Pharma Therapeutics BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, [...]